Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Pathological roles of purinergic signaling in the liver
Byron P. Vaughn
, Simon C. Robson
, Geoffrey Burnstock
Medicine - Gastro, Hepatology, Nutrition Division
Research output
:
Contribution to journal
›
Comment/debate
›
peer-review
60
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pathological roles of purinergic signaling in the liver'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pathological Role
100%
Liver
100%
Purinergic Signaling
100%
P2 Receptors
50%
Extracellular nucleotides
50%
Pathophysiology
25%
Fibrosis
25%
Malignancy
25%
Clinical Application
25%
Adenosine
25%
ATP Metabolism
25%
Transplantation
25%
Ischemia-reperfusion Injury
25%
Liver Regeneration
25%
Pathobiology
25%
Receptor Signaling
25%
Receptor Activation
25%
Extracellular ATP (eATP)
25%
Cellular Signaling
25%
Cellular Response
25%
Liver Disease
25%
Disease States
25%
Nucleosides
25%
Gluconeogenesis
25%
Metabolic Processes
25%
Ectoenzymes
25%
Purinergic Receptors
25%
Insulin Responsiveness
25%
Pathologic Processes
25%
Liver Inflammation
25%
Multiple Diseases
25%
Chronic Hepatic Disease
25%
Ectonucleotidases
25%
P1 Receptors
25%
Danger Signals
25%
Steatosis
25%
Liver Immunity
25%
Normal Physiology
25%
Medicine and Dentistry
Adenosine Triphosphate
100%
Liver Disease
66%
Purinergic P2 Receptor
66%
Biological Product
33%
Ischemia
33%
Pathophysiology
33%
Cancer
33%
Adenosine
33%
Physical Disease by Body Function
33%
Fibrosis
33%
Gluconeogenesis
33%
Steatosis
33%
Nucleoside
33%
Adenosine Receptor
33%
Purinergic Receptor
33%
Comorbidity
33%
Diseases
33%
Pharmacology, Toxicology and Pharmaceutical Science
Adenosine Triphosphate
100%
Liver Disease
66%
Purinergic P2 Receptor
66%
Physical Disease by Body Function
33%
Ischemia
33%
Biological Product
33%
Steatosis
33%
Pathophysiology
33%
Fibrosis
33%
Nucleoside
33%
Adenosine
33%
Purinergic Receptor
33%
Adenosine Receptor
33%
Comorbidity
33%
Diseases
33%
Biochemistry, Genetics and Molecular Biology
Adenosine Triphosphate
100%
P2 Receptor
66%
Metabolic Pathway
33%
Ectonucleotidase
33%
Adenosinergic
33%
Ectoenzyme
33%
Reperfusion
33%
Gluconeogenesis
33%
Nucleoside
33%
Purinergic Receptor
33%
Adenosine Receptor
33%
Comorbidity
33%
Adenosine
33%